Page 6 - Ochsner_Outcomes_General_Surgery

ESOPHAGEAL DISEASE
Ochsner’s multidisciplinary Swallowing team brings together general surgeons who are experts in minimally invasive techniques; ear, nose and throat specialists; thoracic surgeons; surgical oncologists; gastroenterologists; radiologists; speech therapists; neurologists; nutrition specialists; medical oncologists and swallowing therapists, all dedicated to caring for patients with disorders of the esophagus.
Upper GI Cancer
Our expert team leads the Gulf South in the treatment of upper GI cancers (esophageal, gastric and pancreatic). We take special measures to ensure the comfort and education of our patients and their family members, knowing they all play important roles in the recovery process. Ochsner is a national leader in minimizing complications and carrying out successful multimodality treatment. The medical staff is also experienced in
the evaluation of high-risk Barrett’s syndrome and the performance of laparoscopic-assisted or robotic, minimally invasive esophagectomy, gastrectomy and pancreatectomy. All cases of upper GI cancer are presented at our twice- weekly tumor board, using an integrated multispecialty approach, where medical, radiation and surgical oncology specialists discuss each patient, mapping
out an individualized treatment plan.
The Ochsner Esophageal Surgery Program leads the Gulf Coast in the treatment of benign and malignant esophageal disease. The multidisciplinary team includes surgeons, gastroenterologists, medical and radiation oncologists, speech pathologists and dieticians and evaluates more than 140 new patients per year with diagnoses ranging from motility disorders to complex tumor cases. Experienced general surgeons and surgical oncologists offer minimally invasive fundoplication, myotomy, paraesophageal hernia repair and esophageal resection, frequently employing surgical robotics. Ochsner is a high-volume center for esophagectomy, performing more than 30 of these complex procedures each year, including colon interposition. Patients are presented at separate multidisciplinary benign and malignant conferences to ensure a patient-centered treatment strategy. Partnering with gastroenterologists with advanced interventional skills, Ochsner can offer endoscopic resection for high-grade dysplasia and
T1a esophageal cancers. Research is highlighted by clinical trials for cancer patients and surgical outcomes research. A tremendous focus on reducing surgical morbidity through evidence-based enhanced recovery pathways has allowed us to maintain complication
and mortality indexes below 1.0 while minimizing postoperative length of stay.
6OCHSNEROUTCOMES